BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12010224)

  • 1. Risk factors for developing renal stones in inflammatory bowel disease.
    McConnell N; Campbell S; Gillanders I; Rolton H; Danesh B
    BJU Int; 2002 Jun; 89(9):835-41. PubMed ID: 12010224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
    Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
    Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
    Siener R; Ernsten C; Speller J; Scheurlen C; Sauerbruch T; Hesse A
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal stone formation in patients with inflammatory bowel disease.
    Caudarella R; Rizzoli E; Pironi L; Malavolta N; Martelli G; Poggioli G; Gozzetti G; Miglioli M
    Scanning Microsc; 1993 Mar; 7(1):371-9; discussion 379-80. PubMed ID: 8316806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary factors of kidney stone formation in patients with Crohn's disease.
    Böhles H; Beifuss OJ; Brandl U; Pichl J; Akçetin Z; Demling L
    Klin Wochenschr; 1988 Feb; 66(3):87-91. PubMed ID: 3352194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease.
    Hylander E; Jarnum S; Frandsen I
    Scand J Gastroenterol; 1979; 14(4):475-9. PubMed ID: 482860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crohn's disease and kidney stones: much more than coincidence?].
    Viana ML; Pontes RM; Garcia WE; Fávero ME; Prete DC; Matsuo T
    Arq Gastroenterol; 2007; 44(3):210-4. PubMed ID: 18060273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary saturation and risk factors for calcium oxalate stone disease based on spot and 24-hour urine specimens.
    Ogawa Y; Yonou H; Hokama S; Oda M; Morozumi M; Sugaya K
    Front Biosci; 2003 Sep; 8():a167-76. PubMed ID: 12957883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
    Bianchi L; Gaiani F; Bizzarri B; Minelli R; Cortegoso Valdivia P; Leandro G; Di Mario F; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):76-80. PubMed ID: 30561398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequency of colonization with Oxalobacter formigenes in inflammatory bowel disease: possible role in renal stone formation.
    Kumar R; Ghoshal UC; Singh G; Mittal RD
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1403-9. PubMed ID: 15610315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent urinary stone events are predicted by the magnitude of urinary oxalate excretion in enteric hyperoxaluria.
    D'Costa MR; Kausz AT; Carroll KJ; Ingimarsson JP; Enders FT; Mara KC; Mehta RA; Lieske JC
    Nephrol Dial Transplant; 2021 Dec; 36(12):2208-2215. PubMed ID: 33367720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrolithiasis in childhood inflammatory bowel disease.
    Clark JH; Fitzgerald JF; Bergstein JM
    J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):829-34. PubMed ID: 2995632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stones from bowel disease.
    Worcester EM
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):979-99. PubMed ID: 12474641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.